指南与共识甲状腺疾病

甲状腺乳头状癌高细胞亚型的病理报告:我们是否已达成共识?

Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus?
指南 / 共识 · Thyroid · 2017-11-07

本研究将17例病理报告中含「高细胞」诊断的甲状腺癌手术切除标本和22例经典型甲状腺乳头状癌(PTC)病例数字化,由14位专家病理学家在不知原始诊断的情况下盲法阅片,判断是否为高细胞亚型(TCV)并回答诊断性组织病理学特征相关问题。结果显示专家间识别TCV的一致性为一般(Fleiss kappa 0.34),观察一致比例为0.70;22例原诊断为经典型PTC的病例中,15例(68%)被至少一位专家病理学家重新分类为TCV。结论认为TCV的病理报告存在差异,源于缺乏统一诊断标准及个体判读差异,需进一步研究以达成TCV诊断标准的共识。

要点

  • 14位专家病理学家盲法阅片识别TCV的总体一致性为一般(Fleiss kappa 0.34),观察一致比例为0.70。
  • 22例原诊断为经典型PTC的病例中,15例(68%)被至少一位专家病理学家重新分类为TCV。
  • 参与者基于细胞高宽比(H:W)及显示该比值的肿瘤细胞百分比的不同组合,使用了四种不同的TCV定义。

核心结论

  • TCV的病理报告在不同病理学家间存在差异,源于缺乏统一诊断标准及个体判读差异,导致TCV的过度诊断与诊断不足,对患者管理有重要影响。
  • 作者认为需进一步研究以就TCV的诊断标准达成共识。

研究设计与样本

  • 选取17例病理报告中含「高细胞」诊断的甲状腺癌手术切除标本及22例经典型PTC病例,数字化后由14位专家病理学家在不知原始诊断的情况下盲法阅片。
  • 每位病理学家判定每例是否为TCV,并回答关于TCV诊断性组织病理学特征的多个问题。

主要发现

  • 识别TCV的总体一致性为一般(Fleiss kappa 0.34),观察一致比例为0.70。
  • 22例原诊断为经典型PTC的病例中,15例(68%)被至少一位专家病理学家重新分类为TCV。
  • 参与者基于细胞高宽比(H:W)及显示该比值的肿瘤细胞百分比的不同组合,使用了四种不同的TCV定义。
  • 所有病理学家一致认为TCV的诊断不能仅依赖特定的H:W比值。

临床怎么用

  • 作者认为需进一步研究以就TCV的诊断标准达成共识。

局限性

  • 需进一步研究以就TCV的诊断标准达成共识。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tall-cell variant (TCV) is widely believed to be a more aggressive subtype of papillary thyroid carcinoma (PTC). Despite the significance of TCV with respect to risk stratification and therapeutic decision making, its diagnosis is subject to inter-observer variability. This study aimed to determine the level of agreement among expert pathologists in the identification and reporting of TCV. METHODS: Seventeen surgical resections for thyroid cancer containing the diagnostic term "tall cell" in their pathology reports and 22 cases diagnosed as classical PTC were selected. Cases were digitalized, and 14 expert pathologists reviewed the scanned slides blinded to the original interpretation. Each pathologist designated each case as TCV or not and answered multiple questions about diagnostic histopathologic features of TCV. RESULTS: The overall strength of agreement for identifying TCV was fair (Fleiss kappa 0.34), and the proportion of observed agreement was 0.70. Of 22 cases originally diagnosed as PTC classical variant, 15 (68%) were reclassified as TCV by at least one expert pathologist. It was noted that four different definitions for TCV were used by the participants based on various combinations of cell height to width (H:W) ratio and the percentage of tumor cells showing that specific ratio. All pathologists agreed that the diagnosis of TCV does not rely solely on a specific H:W ratio. CONCLUSIONS: Pathologic reporting of TCV varies among pathologists. This disagreement is a result of the lack of unanimous diagnostic criteria and variation in individual pathologists' interpretations. These discrepancies lead to over- and under-diagnosis of TCV, which has significant implications in patient management. It is imperative to understand this variability in diagnosis TCV as it relates to risk stratification and interpretation of clinical studies related to this histologic subtype of PTC. Further studies are needed to reach consensus on the diagnostic criteria of TCV.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Hernandez-Prera JC, Machado RA, Asa SL, et al. Pathologic Reporting of Tall-Cell Variant of Papillary Thyroid Cancer: Have We Reached a Consensus? Thyroid. 2017. PMID: 29020884. doi:10.1089/thy.2017.0280

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。